Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Classical hematology 1CNS 1

Conditions

Lymphoma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 18Lymphoma, Non-Hodgkin 17Hodgkin Disease 13Leukemia 11Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, B-Cell 7Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Recurrence 5Immunoblastic Lymphadenopathy 4Lymphoma, T-Cell 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Acute 3Enteropathy-Associated T-Cell Lymphoma 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, T-Cell, Peripheral 2Intraocular Lymphoma 2Wilms Tumor 1Thrombocytopenia 1Testicular Neoplasms 1

Interventions

Rituximab 17Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15fludarabine phosphate 12Whole-Body Irradiation 11Cyclosporine 10Mycophenolic Acid 9Etoposide 9Methotrexate 8Filgrastim 8Lenalidomide 7Tacrolimus 6Dexamethasone 6Busulfan 6Radiotherapy 5Melphalan 5Cytarabine 5Carboplatin 5Vorinostat 4Thiotepa 4Therapeutics 4Psychiatric Rehabilitation 4Bortezomib 4Antilymphocyte Serum 4Transplantation 3Methylprednisolone 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dasatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Intraocular Lymphoma × etoposide phosphate × Lymphoid × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00074178 2017-04-21

Protocol-B

OHSU Knight Cancer Institute

Phase 2 Completed
22 enrolled
Lymphoid

Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡